Provided by Tiger Trade Technology Pte. Ltd.

Erasca, Inc.

15.70
-0.5800-3.56%
Pre-market: 15.720.0200+0.13%04:42 EDT
Volume:4.04M
Turnover:64.70M
Market Cap:5.49B
PE:-16.17
High:16.70
Open:16.06
Low:15.67
Close:16.28
52wk High:24.28
52wk Low:1.53
Shares:349.76M
Float Shares:291.15M
Volume Ratio:0.92
T/O Rate:1.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9710
EPS(LYR):-0.4393
ROE:-78.25%
ROA:-21.39%
PB:15.17
PE(LYR):-35.74

Loading ...

Erasca reports Q2 EPS (14c), consensus (11c)

TIPRANKS
·
Aug 12

Erasca Rugi Bersih Q2 FY26 Melebar 30,12% Jadi USD 44,08 Juta

Reuters
·
Aug 12

Erasca Q2 Basic EPS USD -0.14

THOMSON REUTERS
·
Aug 12

Press Release: Erasca Reports Second Quarter 2026 Business Updates and Financial Results

Dow Jones
·
Aug 12

Erasca Grants New R&D Chief Charles Fuchs Options for 1,278,520 Shares Under Inducement Plan

Reuters
·
Aug 11

Press Release: Erasca Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Dow Jones
·
Aug 11

Erasca Appoints Charles Fuchs as President of R&D

Reuters
·
Aug 10

Erasca Strengthens R&D Leadership with Appointment of Internationally Recognized Medical Oncologist Charles S. Fuchs, M.D., M.P.H., as President of R&D

GlobeNewswire
·
Aug 10

Erasca is Maintained at Equal-weight by Morgan Stanley

Dow Jones
·
Jul 20

Erasca price target raised to $21 from $12 at Morgan Stanley

TIPRANKS
·
Jul 20

Analysts Have Conflicting Sentiments on These Healthcare Companies: Trevi Therapeutics (TRVI), Amneal Pharmaceuticals (AMRX) and Erasca (ERAS)

TIPRANKS
·
Jul 20

Erasca, Inc. : Morgan Stanley Raises Target Price to $21.00 from $12.00

THOMSON REUTERS
·
Jul 20

Erasca Faces Investor Lawsuit Over Clinical Data and Patent Allegations

Deep News
·
Jul 17

Movement Alert|Erasca Falls 5.27% in Regular Trading, $632.5 Million Upsized Stock Offering Sparks Dilution Concerns

Market Focus
·
Jul 16

Erasca Closes Upsized Public Stock Offering Raising USD 632.5 Million

Reuters
·
Jul 16

Press Release: Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Dow Jones
·
Jul 16

Movement Alert|Erasca Rises 5.41% in Regular Trading, Positive Phase 1 Data and Registration Plans Boost Market Confidence

Market Focus
·
Jul 15

Erasca Announces Major Equity Offering to Fund Oncology

TIPRANKS
·
Jul 15

Erasca Unveils Updated Cancer Candidate Progress, Maps Path Toward Pivotal Cancer Trials

Benzinga Earnings
·
Jul 15

Erasca 31.429M share Spot Secondary priced at $17.50

TIPRANKS
·
Jul 14